Clearside Biomedical Inc Cash Flow-to-Debt Ratio
Clearside Biomedical Inc cash flow-to-debt ratio. Clearside Biomedical Inc (CLSD) has a Cash Flow-to-Debt Ratio of -0.08x as of September 2025, meaning its operating cash flow of $-5.48 Million could theoretically repay 0% of its total liabilities ($65.59 Million) in one year. Check Clearside Biomedical Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Clearside Biomedical Inc (2012–2024)
Cash flow-to-debt ratio of Clearside Biomedical Inc from 2012 to 2024. Historical debt coverage capacity for Clearside Biomedical Inc across 13 annual periods. Check CLSD cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Clearside Biomedical Inc Cash Flow-to-Debt Ratio by Year (2012–2024)
Clearside Biomedical Inc cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for Clearside Biomedical Inc. For the full cash flow conversion analysis, see how efficiently does Clearside Biomedical Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.39x | $-24.70 Million | $63.98 Million | ▼ -6.3% |
| 2023 | -0.36x | $-18.14 Million | $49.93 Million | ▼ -10.6% |
| 2022 | -0.33x | $-13.37 Million | $40.70 Million | ▲ +84.9% |
| 2021 | -2.18x | $-10.73 Million | $4.93 Million | ▼ -75.3% |
| 2020 | -1.24x | $-13.12 Million | $10.56 Million | ▲ +28.3% |
| 2019 | -1.73x | $-27.07 Million | $15.62 Million | ▲ +55.1% |
| 2018 | -3.86x | $-79.20 Million | $20.50 Million | ▼ -44.3% |
| 2017 | -2.68x | $-51.08 Million | $19.08 Million | ▼ -55.1% |
| 2016 | -1.73x | $-22.71 Million | $13.15 Million | ▼ -616.7% |
| 2015 | -0.24x | $-13.90 Million | $57.71 Million | ▲ +22.1% |
| 2014 | -0.31x | $-9.12 Million | $29.51 Million | ▲ +41.8% |
| 2013 | -0.53x | $-6.84 Million | $12.88 Million | ▲ +88.1% |
| 2012 | -4.48x | $-3.18 Million | $709.00K | — |